Minocycline

Tetracyclines, including tetracycline, doxycycline and minocycline have been used for decades for patients with rosacea, because of their anti-inflammatory effects. Although the evidence for treating rosacea with minocycline is not as established as doxycycline, there is some evidence that Minocycline 100mg may be a good alternative treatment for those patients who, for any reason, are unable or unwilling to take doxycycline 40mg. With the release of the topical minocycline Zilxi and configurable dose, extended release minocycline tablets Minolira, minocycline is becoming a better known and accepted rosacea treatment.

Recent Rosacea Blog Posts

DFD-29 set to be approved on Nov 4 2024

News today that Journey Medical Corporation is looking forward to having their Oracea competitor, still known as DFD-29, approved by the FDA before the end of the year. Having accepted the New Drug Application, the FDA is now in the final stages of approving this new 40mg minocycline that is showing promise as a treatment […]

Continue Reading

DFD-29 on it’s way, now has an NDA

Journey Medical’s modified released 40mg minocycline (still code named DFD-29) has published positive Phase 3 Clinical Trial data and is now sitting waiting on a New Drug Application. The company press release touts the combination treatment for both the inflammatory lesions and the redness of rosacea. By comparison, Oracea, the competing product that DFD-29 claims […]

Continue Reading

DFD-29 from Journey Medical may best out Oracea

Journey Medical Corporation are readying to release their Phase 3 clinical trial data for DFD-29, their delayed release 40mg minocycline treatment for rosacea. Targeted as a competitor to Galderma’s successful doxycycline based Oracea, the yet to be named DFD-29 is expected to release clinical data that will demonstrate superior treatment results. According to Journey Medical’s […]

Continue Reading

Minolira for the treatment of rosacea

In 2017, the FDA approved the extended release formulation of minocycline, known as Minolira, for the treatment of severe acne vulgaris. The modified release formulation of doxycycline known as Oracea, was approved for the treatment of rosacea in 2006. As minocycline and doxycycline are related tetracyclines, Minolira may offer rosacea sufferers another rosacea treatment option, […]

Continue Reading

Zilxi good for rosacea for at least a year

A just-published article in the Journal of Clinical & Aesthetic Dermatology confirms that rosacea sufferers who are using Zilxi to treat their papules and pustules can safely continue treatment for at least a year. Further, users can expect the benefit in terms of lesion reduction and satisfaction to increase as the year progresses. This is […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.